SCHEMBL800657

SCHEMBL800657

CC(C)C(=O)CCN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL11705085 0.97
SCHEMBL800654 0.83
SCHEMBL800679 0.81 PAOX (0.52)
SCHEMBL620412 0.81 CA1 (0.36)
SCHEMBL16306456 0.80
SCHEMBL6852635 0.80
SCHEMBL3922773 0.80
SCHEMBL13300751 0.79 PAOX (0.56)
SCHEMBL260557 0.79 PAOX (0.56)
SCHEMBL15364496 0.78 GABRR1 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2545028-A1 A NOVEL STEREOSPECIFIC SYNTHESIS OF (-) (2S,3S)-1-DIMETHYLAMINO-3-(3-METHOXYPHENYL)-2-METHYL PENTAN-3-OL Symed Labs Limited (IN) 2013-01-16 EP claimed
WO-2012101649-A1 A NOVEL STEREOSPECIFIC SYNTHESIS OF (-) (2S,3S)-1-DIMETHYLAMINO-3-(3-METHOXYPHENYL)-2-METHYL PENTAN-3-OL SYMED LABS LIMITED (IN) 2012-08-02 WO claimed
US-11911412-B2 Derivatized chitosan polymers and methods of treating vascular disorders SYNEDGEN, INC. (US) 2024-02-27 US disclosed
US-11786547-B2 Methods and compositions for disrupting biofilm utilizing chitosan-derivative compounds SYNEDGEN, INC. (US) 2023-10-17 US disclosed
US-20230302430-A1 SELENIOUS ACID ADSORBENT NATIONAL UNIVERSITY CORPORATION KANAZAWA UNIVERSITY (JP) 2023-09-28 US disclosed
US-11717532-B2 Methods and compositions for treating wounds utilizing chitosan compounds SYNEDGEN, INC. (US) 2023-08-08 US disclosed
US-11718758-B2 Aqueous dispersion of colored particles MITSUBISHI PENCIL COMPANY, LIMITED (JP) 2023-08-08 US disclosed
US-11717532-B2 Methods and compositions for treating wounds utilizing chitosan compounds SYNEDGEN, INC. (US) 2023-08-08 US disclosed
EP-3725854-B1 COLORED PARTICLE AQUEOUS DISPERSION MITSUBISHI PENCIL CO (JP) 2023-07-05 EP disclosed
US-20230201248-A1 COMPOSITIONS AND METHODS OF USE THEREOF SYNEDGEN, INC. 2023-06-29 US disclosed
US-20230203096-A1 EPHA4 TARGETING COMPOUNDS AND METHODS OF USE THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-06-29 US disclosed
US-7704924-B2 Library of compounds comprising pyrrolobenzodiazepine moieties SPIROGEN LIMITED (GB) 2010-04-27 US disclosed
US-20100056474-A1 Methods and Compositions for the Prevention of and Treatment of Infections Utilizing Chitosan-Derivative Compounds UNITED STATES GOVERNMENT 2010-03-04 US disclosed
US-20100022761-A1 PHOTOCLEAVABLE LINKER METHODS AND COMPOSITIONS THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY 2010-01-28 US disclosed
US-20090075981-A1 INHIBITORS OF p38 VERTEX PHARMACEUTICALS INCORPORATED (US) 2009-03-19 US disclosed
US-20090075981-A1 INHIBITORS OF p38 VERTEX PHARMACEUTICALS INCORPORATED (US) 2009-03-19 US disclosed
US-7481993-B2 Chelators for radioactively labeled conjugates comprising a stabilizing sidechain SCHERING AG (DE) 2009-01-27 US disclosed
US-7423049-B2 Inhibitors of p38 VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-09-09 US disclosed
US-20070060572-A1 Inhibitors of p38 VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-03-15 US disclosed
US-4323363-A DISPERSE DYE USED ON POLYESTERS MIXED WITH CELLULOSE CASSELLA AKTIENGESELLSCHAFT (DE) 1982-04-06 US disclosed